Adlai Nortye (ANL) Current Leases (2022 - 2025)

Adlai Nortye (ANL) reported Current Leases of $667000.0 for Q4 2025, up 41.61% year-over-year from $471000.0 in Q4 2024, and up 41.61% on a QoQ basis from $471000.0 in Q4 2024.

Adlai Nortye (ANL) has 4 years of Current Leases data on file, last reported at $667000.0 in Q4 2025.

  • Quarterly Current Leases rose 41.61% year-over-year to $667000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $667000.0 (up 41.61% YoY) and the FY2025 annual result came in at $667000.0, up 41.61% from the prior year.
  • Current Leases improved to $667000.0 in Q4 2025 per ANL's latest filing, from $471000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.0 million in Q4 2022 and bottomed at $471000.0 in Q4 2024.
  • The 4-year median for Current Leases is $694500.0 (2023), against an average of $715250.0.
  • The widest annual swing landed in 2024, when Current Leases tumbled 34.76%; it then surged 41.61% in 2025.
  • Tracing ANL's Current Leases over 4 years: stood at $1.0 million in 2022, then retreated by 27.87% to $722000.0 in 2023, then plunged by 34.76% to $471000.0 in 2024, then soared by 41.61% to $667000.0 in 2025.
  • Per Business Quant, the three latest ANL Current Leases figures stand at $667000.0 (Q4 2025), $471000.0 (Q4 2024), and $722000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 83,991.00
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 720.00 Mn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 45.66 Mn
10 Adlai Nortye 23,840.00 -8.03 Mn - 667,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 667,000.00
Dec 31, 2024 471,000.00
Dec 31, 2023 722,000.00
Dec 31, 2022 1.00 Mn